[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
[ Fri, Aug 09th 2024 ]: WOPRAI
Laura Chico Maintained (XENE) at Buy with Decreased Target to $49 on, Aug 9th, 2024
- 🞛 This publication is a summary or evaluation of another publication
Laura Chico of Wedbush, Maintained "Xenon Pharmaceuticals Inc." (XENE) at Buy with Decreased Target from $50 to $49 on, Aug 9th, 2024.
Laura has made no other calls on XENE in the last 4 months.
There are 3 other peers that have a rating on XENE. Out of the 3 peers that are also analyzing XENE, 0 agree with Laura's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Laura
- Brian Abrahams of "RBC Capital" Reiterated at Buy and Held Target at $55 on, Tuesday, June 18th, 2024
- David Hoang of "Citigroup" Maintained at Strong Buy with Decreased Target to $60 on, Friday, May 10th, 2024
- Serge Belanger of "Needham" Maintained at Strong Buy and Held Target at $62 on, Friday, May 10th, 2024